Skip to content
MomMetabolicEVIDENCE-FIRST METABOLIC HEALTH
Menu

Alternatives · ranked for women

Alternatives to Tru2u

People usually look past Tru2u because it scores lowest on true monthly cost (20/100) in our rubric, and because ⛔ No product states a supply period — checked on the storefront, in the catalog data and in each product's own data, with no subscription plan attached to any of them.

Where Tru2u is strongest
Ongoing support — 44/100
Semaglutide
$225/period
Tirzepatide
$345/period
Coverage
Not published

Tru2u lands at #282 on our ranking with a Metabolic-Fit Score of 31/100. If it isn't the right fit, here are the strongest alternatives for women's GLP-1 care — scored on the same women's-health rubric of PCOS suitability, clinical oversight, price, access, support and fair cancellation.

Our #1 pick for women

Ranked #1 · Grade A−

CoreAge Rx

One flat price, both molecules on a single chart, and a prescriber who reads your history before writing — the most predictable place for a mother to start and, just as important, to pause.

Semaglutide
$99/mo
Tirzepatide
$149/mo
Coverage
All 50 states
Brand-name
Compounded only

More alternatives, in ranking order

Sesame

Ranked #8 · Grade B−

A real telehealth marketplace with a video visit and a clinician you pick — now brand-first, so you get on-label Wegovy or Zepbound with the manufacturer's own pregnancy labeling, if you can absorb a membership fee stacked on the drug price.

  • serves all 50 states, where Tru2u lists Not published
  • offers FDA-approved brand pens, not just compounded
  • scores 81/100 against Tru2u's 31

Gala Health

Ranked #4 · Grade B

A flat $179 for either molecule with a genuinely gentle microdosing tier — a reasonable, all-doses-included option if you can live with a yearly plan and a pharmacy it doesn't name.

  • serves all 50 states, where Tru2u lists Not published
  • offers FDA-approved brand pens, not just compounded
  • scores 84/100 against Tru2u's 31

ShedRx

Ranked #13 · Grade C

The widest menu on our roster — injections, sublingual lozenges, daily drops, four brand-name pens and the approved oral GLP-1 — with three compounding pharmacies named, a flat price at any dose, and cancellation terms among the most restrictive we have read.

  • serves all 50 states, where Tru2u lists Not published
  • offers FDA-approved brand pens, not just compounded
  • scores 76/100 against Tru2u's 31

SynergyRX

Ranked #14 · Grade C

Now confirmed to publish real GLP-1 prices — compounded semaglutide from $199, tirzepatide from $349, plus brand options — right on its products page, no consult required, contrary to what an earlier check found.

  • serves all 50 states, where Tru2u lists Not published
  • offers FDA-approved brand pens, not just compounded
  • scores 76/100 against Tru2u's 31

Eden

Ranked #2 · Grade B+

⛔ FDA warning letter #728279 (June 2026), which names tryeden.com. The most oversight-forward compounded program here — visible clinician involvement and lab framing — at $196/mo semaglutide or $296/mo tirzepatide, flat and nationwide.

  • serves all 50 states, where Tru2u lists Not published
  • scores 89/100 against Tru2u's 31

AskRx

Ranked #21 · Grade C

AskRx is the most transparent pricing model on this page and it is still not a cheap one, which is worth understanding before you compare it to anything else here. It prescribes FDA-approved drugs only — it says 'No compounded meds' in as many words — so the menu is the Wegovy pen, the Wegovy pill, Zepbound in pen or KwikPen form, and Foundayo, the new oral tirzepatide. What it charges for that is a care fee, itemized in its own footnote rather than buried: $90 a month for the physician visit plus $10 a month fulfilment, $100 in total, with the medication billed separately through AskRx's own pharmacy and, it says, 'at cost — never a markup'. That last claim is the interesting one. Most providers on this page bundle an unknown medication margin into a single number; AskRx unbundles it and shows you both halves at checkout. The catch is the same one that applies to every brand-only route: nobody publishes what a Wegovy pen actually costs you, so $100 is a floor and the real total depends on the drug and on whatever insurance does. For a mother comparing this to a $79 or $115 compounded membership, those are not the same product — one is a manufacturer-made finished drug, the other is compounded — and this is the honest version of the expensive option.

  • serves all 50 states, where Tru2u lists Not published
  • offers FDA-approved brand pens, not just compounded
  • scores 65/100 against Tru2u's 31

CareBareRX

Ranked #18 · Grade C

Both molecules have confirmed, tiered pricing, which appears only inside the signup flow — the public site carries no price at all — with a real gotcha: the 3-month plan costs more per month than month-to-month.

  • serves all 50 states, where Tru2u lists Not published
  • offers FDA-approved brand pens, not just compounded
  • scores 71/100 against Tru2u's 31

Hers

Ranked #24 · Grade C

⛔ An FDA warning letter dated September 2025, over the compounded-semaglutide business it has since left behind. One of the few mass-market brands designed around a woman's front door — now selling FDA-approved brand Wegovy and Zepbound instead of the compounded semaglutide it used to, though the posted price is only half the bill once the required $149/mo membership is added.

  • serves all 50 states, where Tru2u lists Not published
  • offers FDA-approved brand pens, not just compounded
  • scores 63/100 against Tru2u's 31

Breeze Meds

Ranked #11 · Grade C

A clean, all-50-states compounded option with named pharmacies, no membership and the consult included — reasonable and transparent on price, though it's a newer platform with thin public detail beyond the $199 headline.

  • serves all 50 states, where Tru2u lists Not published
  • scores 78/100 against Tru2u's 31

Some outbound links earn MomMetabolic a referral fee at no added cost to you, walled off from the Metabolic-Fit Score. Scores are our editorial judgment per the methodology. Not medical advice; see our disclosure.

← All comparisons